Andrew L. Guggenhime
2016
In 2016, Andrew L. Guggenhime earned a total compensation of $2M as Chief Operating Officer and Chief Financial Officer at Dermira, a 283% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,715 |
|---|---|
| Option Awards | $1,145,816 |
| Salary | $367,430 |
| Stock Awards | $313,144 |
| Total | $2,010,104 |
Guggenhime received $1.1M in option awards, accounting for 57% of the total pay in 2016.
Guggenhime also received $183.7K in non-equity incentive plan, $367.4K in salary and $313.1K in stock awards.
Rankings
In 2016, Andrew L. Guggenhime's compensation ranked 4,863rd out of 14,075 executives tracked by ExecPay. In other words, Guggenhime earned more than 65.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,863 out of 14,075 | 65th |
Division Manufacturing | 1,733 out of 5,486 | 68th |
Major group Chemicals And Allied Products | 543 out of 1,900 | 71st |
Industry group Drugs | 399 out of 1,543 | 74th |
Industry Pharmaceutical Preparations | 317 out of 1,173 | 73rd |
Source: SEC filing on April 28, 2017.
Guggenhime's colleagues
We found four more compensation records of executives who worked with Andrew L. Guggenhime at Dermira in 2016.